90 related articles for article (PubMed ID: 3569402)
1. Activation of the alternative pathway of complement by human serum IgA.
Hiemstra PS; Gorter A; Stuurman ME; Van Es LA; Daha MR
Eur J Immunol; 1987 Mar; 17(3):321-6. PubMed ID: 3569402
[TBL] [Abstract][Full Text] [Related]
2. Activated complement C3: a potentially novel predictor of progressive IgA nephropathy.
Zwirner J; Burg M; Schulze M; Brunkhorst R; Götze O; Koch KM; Floege J
Kidney Int; 1997 Apr; 51(4):1257-64. PubMed ID: 9083294
[TBL] [Abstract][Full Text] [Related]
3. Serum IgA/C3 ratio: a useful marker of disease activity in patients with IgA nephropathy.
Torikoshi K; Endo T; Tsukamoto T; Yasuda T; Yasuda Y; Kawamura T; Matsuo S; Suzuki Y; Muso E
Int Urol Nephrol; 2024 Jun; ():. PubMed ID: 38829466
[TBL] [Abstract][Full Text] [Related]
4. In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19.
Hum Vaccin Immunother; ; . PubMed ID: 38251677
[TBL] [Abstract][Full Text] [Related]
5.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
6.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
